CompletedNot applicableNCT00000959
Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Suspected Latent Tuberculous Infection
Studying Primary genito-urinary tuberculosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Principal Investigator
- Gordin F
- Intervention
- Isoniazid(drug)
- Enrollment
- 600 target
- Eligibility
- 13 years · All sexes
- Timeline
- 1996
Study locations (14)
- UCLA Med Ctr, Los Angeles, California, United States
- Community Consortium of San Francisco, San Francisco, California, United States
- Denver CPCRA / Denver Public Hlth, Denver, Colorado, United States
- Hill Health Corp, New Haven, Connecticut, United States
- Wilmington Hosp / Med Ctr of Delaware, Wilmington, Delaware, United States
- Veterans Administration Med Ctr / Regional AIDS Program, Washington D.C., District of Columbia, United States
- AIDS Research Consortium of Atlanta, Atlanta, Georgia, United States
- Louisiana Comm AIDS Rsch Prog / Tulane Univ Med, New Orleans, Louisiana, United States
- Comprehensive AIDS Alliance of Detroit, Detroit, Michigan, United States
- North Jersey Community Research Initiative, Newark, New Jersey, United States
- Addiction Research and Treatment Corp, Brooklyn, New York, United States
- Clinical Directors Network of Region II, New York, New York, United States
- Harlem AIDS Treatment Group / Harlem Hosp Ctr, New York, New York, United States
- Bronx Lebanon Hosp Ctr, The Bronx, New York, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00000959 on ClinicalTrials.govOther trials for Primary genito-urinary tuberculosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT05917210Peer-led Implementation of TB-HIV Education and Adherence Counseling in UgandaYale University
- RECRUITINGNCT07312266Questioning the Epidemiology of Asymptomatic TBBarcelona Institute for Global Health
- RECRUITINGNANCT05842161South Africa Smoking Cessation and Engagement in HIV/TB Care CareMassachusetts General Hospital
- RECRUITINGPHASE3NCT05575518A Pragmatic Trial With Optimized Dose of Rifampicin and Moxifloxacin for the Treatment of Drug Susceptible Pulmonary TuberculosisStellah Mpagama
- ACTIVE NOT RECRUITINGPHASE4NCT05118490Comparing Treatment Completion Of Daily Rifapentine & Isoniazid For One Month (1HP) To Weekly High Dose Rifapentine & Isoniazid For 3 Months (3HP) In Persons Living With HIV and in Household Contacts of Recently Diagnosed Tuberculosis PatientsThe Aurum Institute NPC
- RECRUITINGNANCT05342064Closing -TB GAPs - for People Living With HIV: TB Guidance for Adaptable Patient-Centered ServiceBaylor College of Medicine